Suenaga M - Search Results

1

Colliding gastric and intestinal phenotype well-differentiated adenocarcinoma of the stomach developing in an area of MALT-type lymphoma.

Suenaga M, Ohta K, Toguchi M, Sato T, Ohyama S, Yamaguchi T, Muto T, Yanagisawa A, Kato Y. Suenaga M, et al. Gastric Cancer. 2003;6(4):270-6. doi: 10.1007/s10120-003-0260-5. Gastric Cancer. 2003. PMID: 14716524

2

Klippel-Trenaunay-Weber syndrome and duodenal hemorrhage.

Sato T, Ohta K, Ohyama S, Suenaga M, Ueno M, Oya M, Yamamoto J, Yamaguchi T, Muto T, Kato Y. Sato T, et al. Among authors: suenaga m. Gastrointest Endosc. 2003 Nov;58(5):756-7. doi: 10.1016/s0016-5107(03)02001-7. Gastrointest Endosc. 2003. PMID: 14595316 No abstract available.

3

The repeated hepatectomy for frequent recurrence of hepatic metastasis from gastrointestinal stromal tumor of the stomach.

Sato T, Ohyama S, Kokudo N, Suenaga M, Yamamoto J, Yamaguchi T, Muto T. Sato T, et al. Among authors: suenaga m. Hepatogastroenterology. 2004 Jan-Feb;51(55):181-3. Hepatogastroenterology. 2004. PMID: 15011859

4

Anal canal carcinoma with Pagetoid spread: report of a case.

Suenaga M, Oya M, Ueno M, Yamamoto J, Yamaguchi T, Mizunuma N, Hatake K, Kato Y, Muto T. Suenaga M, et al. Surg Today. 2006;36(7):666-9. doi: 10.1007/s00595-006-3215-8. Surg Today. 2006. PMID: 16794808

5

Modified irinotecan plus bolus 5-fluorouracil/L-leucovorin for metastatic colorectal cancer at a single institution in Japan.

Suenaga M, Mizunuma N, Shouji D, Shinozaki E, Matsusaka S, Chin K, Oya M, Yamaguchi T, Muto T, Hatake K. Suenaga M, et al. J Gastroenterol. 2008;43(11):842-8. doi: 10.1007/s00535-008-2242-1. Epub 2008 Nov 18. J Gastroenterol. 2008. PMID: 19012037

6

Chemotherapy for small-bowel Adenocarcinoma at a single institution.

Suenaga M, Mizunuma N, Chin K, Matsusaka S, Shinozaki E, Oya M, Ueno M, Yamaguchi T, Muto T, Konishi F, Hatake K. Suenaga M, et al. Surg Today. 2009;39(1):27-31. doi: 10.1007/s00595-008-3843-2. Epub 2009 Jan 8. Surg Today. 2009. PMID: 19132464

7

Management of allergic reactions to oxaliplatin in colorectal cancer patients.

Suenaga M, Mizunuma N, Shinozaki E, Matsusaka S, Chin K, Muto T, Konishi F, Hatake K. Suenaga M, et al. J Support Oncol. 2008 Nov-Dec;6(8):373-8. J Support Oncol. 2008. PMID: 19149322

8

How do we apply adjuvant FOLFOX to Japanese patients with curatively resected colorectal cancer?

Suenaga M, Matsusaka S, Watanabe T, Kuboki Y, Shinozaki E, Chin K, Mizunuma N, Ueno M, Yamaguchi T, Hatake K. Suenaga M, et al. Asia Pac J Clin Oncol. 2011 Jun;7(2):129-35. doi: 10.1111/j.1743-7563.2011.01385.x. Asia Pac J Clin Oncol. 2011. PMID: 21585692

9

Predictors of the efficacy of FOLFIRI plus bevacizumab as second-line treatment in metastatic colorectal cancer patients.

Suenaga M, Matsusaka S, Ueno M, Yamamoto N, Shinozaki E, Mizunuma N, Yamaguchi T, Hatake K. Suenaga M, et al. Surg Today. 2011 Aug;41(8):1067-74. doi: 10.1007/s00595-010-4432-8. Epub 2011 Jul 20. Surg Today. 2011. PMID: 21773895

10

Total mesorectal excision of initially unresectable locally advanced rectal cancer infiltrating the pelvic wall after treatment with FOLFOX4 plus bevacizumab and preoperative chemoradiation: report of a case.

Itatani Y, Akiyoshi T, Kuroyanagi H, Yamakawa K, Noaki R, Konishi T, Fujimoto Y, Ueno M, Oya M, Suenaga M, Yamaguchi T. Itatani Y, et al. Among authors: suenaga m. Surg Today. 2012 Jan;42(1):75-9. doi: 10.1007/s00595-011-0004-9. Epub 2011 Nov 12. Surg Today. 2012. PMID: 22075663

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

370 results

Search Page